Ofichem signs agreement to acquire US-based Kinentia Biosciences, creating transatlantic development & manufacturing platform of Drug Substances
05 Oct 26
Read more
Work shoulder-to-shoulder with a family-owned CDMO and pharmaceutical supplier that answers quickly, solves early, and keeps your progress steady. Decisions feel clearer with us beside you.